Table 10.6a

Immunosuppression Use for Induction, 1995 to 2004

Recipients with Intestine Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Transplants 46 45 68 70 73 81 111 107 116 152
With Immunosuppression Info 43 33 66 68 71 79 111 106 116 148
Induction Drugs 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
ALG
Atgam/NRATG/NRATS 0.0% 3.0% 3.0% 0.0% 0.0% 1.3% 0.0% 0.9% 1.7% 2.7%
OKT3 7.0% 12.1% 4.5% 2.9% 9.9% 5.1% 7.2% 1.9% 1.7% 0.7%
Thymoglobulin 0.0% 0.0% 0.0% 0.0% 4.2% 0.0% 12.6% 31.1% 45.7% 18.2%
Zenapax 0.0% 0.0% 0.0% 36.8% 49.3% 55.7% 23.4% 10.4% 16.4% 8.8%
Simulect 0.0% 0.0% 0.0% 1.5% 1.4% 12.7% 13.5% 13.2% 1.7% 0.7%
Campath 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 8.6% 18.9%
No Induction Drugs Recorded 93.0% 84.8% 92.4% 58.8% 39.4% 30.4% 43.2% 42.5% 25.9% 50.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.